BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18634281)

  • 1. [Angiogenesis in the chronic inflammatory diseases and malignancies].
    Mizia-Malarz A; Sobol G; Woś H
    Pol Merkur Lekarski; 2008 Mar; 24(141):185-9. PubMed ID: 18634281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proangiogenic factors: vascular-endothelial growth factor (VEGF) and basic fibroblast growth factor--the characteristics and function].
    Mizia-Malarz A; Sobol G; Woś H
    Przegl Lek; 2008; 65(7-8):353-7. PubMed ID: 19004235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour's angiogenesis--the function of VEGF and bFGF in colorectal cancer.
    Kos M; Dabrowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):556-61. PubMed ID: 12898895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitivity CRP and serum amyloid A as expressions of low grade inflammation do not correlate with bFGF or VEGF.
    Larsson A; Hansson LO
    Ups J Med Sci; 2003; 108(1):51-9. PubMed ID: 12903837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice.
    del Rey MJ; Izquierdo E; Caja S; Usategui A; Santiago B; Galindo M; Pablos JL
    Arthritis Rheum; 2009 Oct; 60(10):2926-34. PubMed ID: 19790065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour vascularisation: a druggable target.
    Bishop-Bailey D
    Curr Opin Pharmacol; 2009 Apr; 9(2):96-101. PubMed ID: 19056315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF inhibition: insights from preclinical and clinical studies.
    Crawford Y; Ferrara N
    Cell Tissue Res; 2009 Jan; 335(1):261-9. PubMed ID: 18766380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma.
    Jang FF; Wei W; De WM
    J Ayub Med Coll Abbottabad; 2008; 20(2):105-9. PubMed ID: 19385471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment.
    Ngo TC; Gonzalgo ML
    J Urol; 2010 May; 183(5):1750. PubMed ID: 20299036
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiogenic factor expression in hepatic cirrhosis.
    Giatromanolaki A; Kotsiou S; Koukourakis MI; Sivridis E
    Mediators Inflamm; 2007; 2007():67187. PubMed ID: 17497037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current insights on the biology and clinical aspects of VEGF regulation.
    Birk DM; Barbato J; Mureebe L; Chaer RA
    Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
    Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T
    Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies.
    Ribatti D; Vacca A; Rusnati M; Presta M
    Cytokine Growth Factor Rev; 2007; 18(3-4):327-34. PubMed ID: 17537668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the temporal expression of regulatory growth factors during choroidal neovascular development.
    Hu W; Criswell MH; Fong SL; Temm CJ; Rajashekhar G; Cornell TL; Clauss MA
    Exp Eye Res; 2009 Jan; 88(1):79-91. PubMed ID: 19013152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and its relationship to inflammatory mediators.
    Angelo LS; Kurzrock R
    Clin Cancer Res; 2007 May; 13(10):2825-30. PubMed ID: 17504979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
    Ciulla TA; Rosenfeld PJ
    Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the current research on the role of bFGF and VEGF in angiogenesis.
    Przybylski M
    J Wound Care; 2009 Dec; 18(12):516-9. PubMed ID: 20081577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular remodelling in asthma.
    Walters EH; Soltani A; Reid DW; Ward C
    Curr Opin Allergy Clin Immunol; 2008 Feb; 8(1):39-43. PubMed ID: 18188016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.